WealthOne’s Invesco Pharmaceuticals ETF PJP Stock Holding History

WealthOne’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-220	Closed	-$14K	–	413
2018 Q4	$14K	Buy	+220	New	+$14.8K	0.01%	331

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

WealthOne's PJP Position: Q1 2019 in Review

WealthOne sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2019, closing a stake of 220 shares — an estimated $14K sold.

WealthOne first reported a position in PJP in Q4 2018 and held it in 1 quarter. The position peaked at $14K in Q4 2018. 95 funds tracked by Wall St. Rank hold PJP as of Q1 2019.

WealthOne reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
WealthOne sold 220 Invesco Pharmaceuticals ETF shares in Q1 2019, an estimated $14K.
WealthOne first reported a position in Invesco Pharmaceuticals ETF in Q4 2018 and held it in 1 quarter.
WealthOne's Invesco Pharmaceuticals ETF position peaked at $14K in Q4 2018.
95 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2019.

Based on WealthOne's 13F filing for Q1 2019, filed 16 May 2019.